Amada Oceania Melbourne Office

Technovalia is a privately owned Australian biotech company located in Mulgrave, Victoria, specializing in the research and development of innovative vaccines and diagnostics. Through partnerships with various academic organizations and international companies, the firm is committed to enhancing protection against infectious diseases by developing safer, more stable, and cost-effective healthcare solutions. In response to the COVID-19 pandemic, Technovalia has been collaborating with BioNet Asia to advance the development of gene-based COVID-19 vaccines, including a DNA-based option currently in preclinical stages and an mRNA vaccine under research. This initiative emphasizes their dedication to ensuring rapid and efficient access to vaccines for Australians while maintaining compliance with Good Manufacturing Practices. Generated from the website